Helicobacter Pylori Test Market to Reach USD 1.35 Billion by 2034

Pune, India, November 2025 - According to a new report by Exactitude Consultancy, the Global Helicobacter Pylori Test Market is valued at USD 900 million in 2024 and is projected to reach USD 1.35 billion by 2034, growing at a CAGR of 4.1% during 2025-2034. The market's growth is driven by the rising global burden of gastric ulcers, gastritis, and stomach cancer, as well as increasing demand for rapid and non-invasive diagnostic solutions.

Download Full PDF Sample Copy of Market Report @

https://exactitudeconsultancy.com/request-sample/49861

Key Takeaways
• Market Size (2024): USD 900 Million
• Forecast (2034): USD 1.35 Billion
• CAGR (2025-2034): 4.1%
• Key Growth Drivers: Rising prevalence of H. pylori infections, growing adoption of urea breath tests and stool antigen tests, and technological advances in molecular detection.
• Leading Companies: Abbott Laboratories, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., Meridian Bioscience Inc., Sekisui Diagnostics, QuidelOrtho Corporation, and DiaSorin S.p.A.

Market Story
Helicobacter pylori (H. pylori) infection is one of the most common chronic bacterial infections, affecting nearly half of the global population and serving as a major cause of peptic ulcers and gastric carcinoma. Growing awareness and preventive screening initiatives have fueled the adoption of rapid and accurate testing methods in both hospital and home settings.

Non-invasive testing technologies-such as urea breath tests, stool antigen assays, and serological tests-are replacing traditional invasive biopsy-based diagnostics. Additionally, molecular PCR-based assays and AI-integrated image analysis in endoscopy are enhancing diagnostic accuracy and treatment monitoring.
Emerging trends include home-based diagnostic kits, integration of digital health data for infection tracking, and increasing government initiatives for early gastric cancer detection programs, especially across Asia-Pacific and Latin America.

Explore Full Report here:
https://exactitudeconsultancy.com/reports/49861/helicobacter-pylori-test-market

Market Segmentation
By Test Type:
• Urea Breath Test
• Stool Antigen Test
• Serology Test
• Biopsy-Based Test
• Molecular Diagnostic Test

By Method:
• Invasive
• Non-Invasive

By End-User:
• Hospitals & Clinics
• Diagnostic Laboratories
• Homecare Settings
• Research Institutes

By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Recent Developments
• 2025: Abbott Laboratories launched a next-gen urea breath analyzer integrated with digital health data transmission for remote diagnosis.
• 2024: Roche Diagnostics introduced a fully automated PCR-based platform for H. pylori detection with antibiotic resistance profiling.
• 2024: Meridian Bioscience expanded its rapid antigen test line with improved sensitivity and shelf-life for decentralized testing.
• 2023: DiaSorin S.p.A. partnered with gastroenterology networks to deploy its molecular testing systems in emerging markets.

Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=49861

Expert Insight
"The shift toward early, accurate, and non-invasive diagnosis is redefining H. pylori management," said Irfan Tamboli, Business Development Executive at Exactitude Consultancy.
"Integration of molecular diagnostics, home test kits, and AI-assisted gastroenterology imaging will shape the future of digestive disease screening and prevention."

Regional Outlook
• Asia Pacific dominates the market with over 45% share due to the high prevalence of H. pylori infection in countries like China, India, and Japan.
• North America shows steady growth fueled by adoption of digital and AI-based diagnostics and preventive gastroenterology programs.
• Europe follows with advanced laboratory infrastructure and reimbursement support for early infection screening.
• Latin America & Middle East are emerging markets witnessing rapid adoption of affordable point-of-care testing kits.

Conclusion
The Helicobacter Pylori Test Market is evolving toward non-invasive, high-accuracy, and digitally connected diagnostic platforms. With growing healthcare awareness, telemedicine adoption, and the rise of molecular testing, the next decade will see early detection and personalized treatment become standard in gastrointestinal care.

This report is also available in the following languages : Japanese (ヘリコバクターピロリ検査市場), Korean (헬리코박터 파일로리 테스트 마켓), Chinese (幽门螺杆菌检测市场), French (Marché test d'Helicobacter pylori), German (Markt für Helicobacter-pylori-Tests), and Italian (Mercato dei test per l'Helicobacter Pylori), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/49861

Our More Reports:

Cardiac Biomarkers Market
https://exactitudeconsultancy.com/reports/49877/cardiac-biomarkers-market

Medical Drones Market
https://exactitudeconsultancy.com/reports/65801/medical-drones-market

4D Printing Healthcare Market
https://exactitudeconsultancy.com/reports/49881/4d-printing-healthcare-market

Critical Illness Insurance Market
https://exactitudeconsultancy.com/reports/49887/critical-illness-insurance-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.